GE Infant Warmer Recalled Due to Oxygen Mixer Problems

|

A recall has been issued for resuscitation systems installed in infant warmers, due to a possible manufacturing error that may reverse the oxygen mixing concentrations, posing a risk of serious and potentially life-threatening injuries for infants receiving the treatment.

GE Healthcare notified consumers in October 2012 about potential problems’s with the company’s resuscitation systems with blenders, which are installed in GE Giraffe and Panda infant warmers. However, the FDA determined last week that the action constitutes a Class I medical device recall, suggesting that continued use of the resuscitation systems carries a reasonable probability of serious adverse health consequences or death.

The oxygen and air inlet fittings and labels located on the back panel of the device may have been reversed during assembly, which could cause the air and oxygen concentrations to potentially reverse. As a result, the setting of the blender knob may not inaccurately reflect the amount of oxygen produced.

Spinal-Cord-Stimulation-Lawsuit
Spinal-Cord-Stimulation-Lawsuit

The recall consists of field upgrade kits for GE Healthcare’s resuscitation systems with blender, installed in GE Giraffe and Panda infant warmers manufactured between April 2008 and September 2012.

GE Healthcare began notifying customers with affected units by sending an “Urgent Medical Device” letter in October, consisting of instructions and illustrations to allow hospital personnel to inspect and correct the device immediately and how to confirm their receipt of the letter.

Consumers with affected products should stop using the product immediately and contact GE Healthcare Customer Service at 1-800-345-2700 to schedule an inspection and mitigation.

Russell Maas
Written by: Russell Maas

Managing Editor & Senior Legal Journalist

Russell Maas is a paralegal and the Managing Editor of AboutLawsuits.com, where he has reported on mass tort litigation, medical recalls, and consumer safety issues since 2010. He brings legal experience from one of the nationโ€™s leading personal injury law firms and oversees the siteโ€™s editorial strategy, including SEO and content development.

Image Credit: |



0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

The second Bard PowerPort bellwether trial is now scheduled to begin in August after the plaintiff in a claim originally planned for trial next month died, and her family stopped pursuing litigation.
A Delaware woman has filed a Dupixent lawsuit, claiming manufacturers promoted the eczema drug as a breakthrough treatment while failing to warn that it may trigger or worsen CTCL, a rare form of non-Hodgkinโ€™s lymphoma.
Federal regulators have expanded an Omnipod recall after reports that internal tubing defects may cause insulin leaks and under-delivery, potentially triggering dangerous blood sugar spikes.